logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Mary Bird Perkins Cancer Center - Essen Lane (Main Campus)

+12257670847
Source: Site record.
https://marybird.org/batonrouge

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Google.

Mary Bird Perkins Cancer Center is Louisiana’s leading cancer care organization, caring for more patients each year than any other facility in the region. And with strategic hospital and physician partnerships, we are delivering on our mission to improve survivorship and lessen the burden of cancer. Mary Bird Perkins and its partners work together to provide state-of-the-art treatments and unparalleled collaborative, comprehensive cancer services. This culture of innovation helps attract the best cancer minds in the country, from expert physicians and highly specialized scientists to forward-thinking leaders in supportive care and other disciplines.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Cancer treatment center

Business Subcategory

Source: Google. Cancer treatment center
Source: Google. Oncologist
Source: Google. Radiologist
Source: Trial-derived.
180Total Trials
Source: Trial-derived.
30Recruiting Trials
Source: Trial-derived.
120Active Trials
Source: Trial-derived.
43Completed Trials
Source: Trial-derived.
641Unique Conditions
Source: Trial-derived.
72Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Recurrent Squamous Cell Lung Carcinoma (9)Source: Trial-derived. Stage IV Squamous Cell Lung Carcinoma AJCC v7 (7)Source: Trial-derived. Invasive Breast Carcinoma (6)Source: Trial-derived. Breast Cancer (5)Source: Trial-derived. Prostate Adenocarcinoma (5)Source: Trial-derived. Prostate Cancer (5)Source: Trial-derived. Recurrent Breast Carcinoma (5)Source: Trial-derived. Breast Adenocarcinoma (4)

Sponsors

Source: Trial-derived. National Cancer Institute (NCI) (137)Source: Trial-derived. NRG Oncology (32)Source: Trial-derived. SWOG Cancer Research Network (23)Source: Trial-derived. Alliance for Clinical Trials in Oncology (16)Source: Trial-derived. ECOG-ACRIN Cancer Research Group (11)Source: Trial-derived. Canadian Cancer Trials Group (9)Source: Trial-derived. Radiation Therapy Oncology Group (9)Source: Trial-derived. Eli Lilly and Company (7)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. Echocardiography
Source: AI-inferred. PET-CT
Source: AI-inferred. X-Ray
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Biobanking
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Circulating tumour DNA testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Endoscopy / colonoscopy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Cystoscopy
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. CD4 lymphocyte enumeration
Source: AI-inferred. Electronic trial enrollment system
Source: AI-inferred. HIV viral-load testing
Source: AI-inferred. Stereotactic body radiation therapy (SBRT)
Source: AI-inferred. Tumour response imaging (modality not specified)
Source: AI-inferred. Stereotactic radiosurgery